| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Xinran Qin, Haidong Zo. The role of lipopolysaccharides in diabetic retinopathy. BMC ophthalmology. vol 22. issue 1. 2022-02-23. PMID:35193549. |
diabetic retinopathy (dr) is the most common complication of dm and the leading cause of blindness in the working-age population of the western world. |
2022-02-23 |
2023-08-13 |
Not clear |
| Amir Arabi, Ramin Tadayoni, Hamid Ahmadieh, Toktam Shahraki, Homayoun Nikkha. Update on Management of Non-proliferative Diabetic Retinopathy without Diabetic Macular Edema; Is There a Paradigm Shift? Journal of ophthalmic & vision research. vol 17. issue 1. 2022-02-23. PMID:35194501. |
diabetic retinopathy (dr) is the major cause of visual impairment and blindness in the working-age population. |
2022-02-23 |
2023-08-13 |
Not clear |
| XiuYa Zeng, YouYuan Peng, YanFeng Wang, KeMing Kan. C1q/tumor necrosis factor-related protein-3 (CTRP3) activated by forkhead box O4 (FOXO4) down-regulation protects retinal pericytes against high glucose-induced oxidative damage through nuclear factor erythroid 2-related factor 2 (Nrf2)/Nuclear factor-kappaB (NF-κB) signaling. Bioengineered. vol 13. issue 3. 2022-02-23. PMID:35196182. |
diabetic retinopathy (dr) remains a major cause of blindness among diabetes mellitus patients. |
2022-02-23 |
2023-08-13 |
human |
| Lalit Pukhrambam Singh, Thangal Yumnamcha, Takhellambam S Dev. Mitophagy, Ferritinophagy and Ferroptosis in Retinal Pigment Epithelial Cells Under High Glucose Conditions: Implications for Diabetic Retinopathy and Age-Related Retinal Diseases. JOJ ophthalmology. vol 8. issue 5. 2022-02-21. PMID:35187384. |
diabetic retinopathy (dr) is a devastating disease leading to blindness among majority of working adults around the globe. |
2022-02-21 |
2023-08-13 |
Not clear |
| Bin Li, Da-Chuan Zhang, Xue-Wang Li, Xia-Nan Dong, Wei-Ping Li, Wei-Zu L. [Protective effect of ginsenoside Rg_1 aganist diabetic retinopathy by inhibiting NLRP3 inflammasome in type 2 diabetic mice]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. vol 47. issue 2. 2022-02-18. PMID:35178992. |
diabetic retinopathy(dr), the most common complication of diabetes, is also the main cause of impaired vision and blindness in the middle-aged and the elderly. |
2022-02-18 |
2023-08-13 |
mouse |
| Shanshan Wang, Qing Yu, Yujue Wang, Chunyue Xu, Guoxiang Niu, Rui Li. CircSLC16A12 absence inhibits high glucose-induced dysfunction in retinal microvascular endothelial cells through mediating miR-140-3p/FGF2 axis in diabetic retinopathy. Current eye research. 2022-02-18. PMID:35179428. |
diabetic retinopathy (dr) is a common microvascular complication of diabetes mellitus which can cause irreversible visual impairment and blindness. |
2022-02-18 |
2023-08-13 |
Not clear |
| Xiumiao Li, Junya Zhu, Yuling Zhong, Chang Liu, Mudi Yao, Yanan Sun, Wen Yao, Xisen Ni, Fen Zhou, Jin Yao, Qin Jian. Targeting long noncoding RNA-AQP4-AS1 for the treatment of retinal neurovascular dysfunction in diabetes mellitus. EBioMedicine. vol 77. 2022-02-16. PMID:35172268. |
diabetic retinopathy (dr) is a leading cause of blindness in the working-age population, which is characterized by retinal neurodegeneration and vascular dysfunction. |
2022-02-16 |
2023-08-13 |
Not clear |
| Subhasish Pramanik, Chinmay Saha, Subhankar Chowdhury, Chiranjit Bose, Nitai P Bhattacharyya, Lakshmi Kanta Monda. Decreased Levels of miR-126 and miR-132 in Plasma and Vitreous Humor of Non-Proliferative Diabetic Retinopathy Among Subjects with Type-2 Diabetes Mellitus. Diabetes, metabolic syndrome and obesity : targets and therapy. vol 15. 2022-02-14. PMID:35153496. |
diabetic retinopathy (dr), the leading cause of blindness among working adults, is an urgent public health problem as diabetes mellitus (dm) is increasing at an alarming rate. |
2022-02-14 |
2023-08-13 |
human |
| Xiaolu Wang, Yanqiu Liu, Qian Yang, Yishun Shu, Chao Sun, Li Yin, Jian Zou, Pengfei Zhan, Yangningzhi Wang, Meili Wu, Xusheng Yang, Jiping Cai, Yong Yao, Tianhua Xi. Prostaglandin E2 Promotes Retinal Microvascular Endothelial cell-derived miR-423-5p-containing extracellular vesicles inducing Müller cell activation in diabetic retinopathy. Traffic (Copenhagen, Denmark). 2022-02-12. PMID:35150035. |
diabetic retinopathy (dr) is a common microvascular complication of diabetes mellitus and one of the major causes of visual impairment and blindness in industrialized countries. |
2022-02-12 |
2023-08-13 |
Not clear |
| Deepthi Elizabeth Kurian, Sanjay Kalra, Nitin Kapoo. Screening for diabetic retinopathy in primary care: Future prospects in low-middle income countries. JPMA. The Journal of the Pakistan Medical Association. vol 71. issue 12. 2022-02-12. PMID:35150549. |
diabetic retinopathy (dr) is an urgent public health concern, and it is prudent to prevent dr than face the burden of blindness arising from it. |
2022-02-12 |
2023-08-13 |
Not clear |
| Deepthi Elizabeth Kurian, Sanjay Kalra, Nitin Kapoo. Screening for diabetic retinopathy in primary care: Future prospects in low-middle income countries. JPMA. The Journal of the Pakistan Medical Association. vol 71. issue 12. 2022-02-12. PMID:35150549. |
blindness rate due to dr has shown a decline in developed countries which is not only due to advanced and accessible tertiary care, but also large-scale screening programmes. |
2022-02-12 |
2023-08-13 |
Not clear |
| Maryam Monemian, Hossein Rabban. Directional analysis of intensity changes for determining the existence of cyst in optical coherence tomography images. Scientific reports. vol 12. issue 1. 2022-02-09. PMID:35136133. |
diabetic retinopathy (dr) is an important cause of blindness in people with the long history of diabetes. |
2022-02-09 |
2023-08-13 |
Not clear |
| Moein Ebrahimi, Maryam Balibegloo, Nima Rezae. Monoclonal antibodies in diabetic retinopathy. Expert review of clinical immunology. 2022-02-02. PMID:35105268. |
diabetic retinopathy (dr), as one of the main complications of diabetes, is among the leading causes of blindness and visual impairment worldwide. |
2022-02-02 |
2023-08-13 |
Not clear |
| Nayan Sanjiv, Pawarissara Osathanugrah, Michael Harrell, Nicole H Siegel, Steven Ness, Xuejing Chen, Howard Cabral, Manju L Subramania. Race and ethnic representation among clinical trials for diabetic retinopathy and diabetic macular edema within the United States: A review. Journal of the National Medical Association. 2022-01-26. PMID:35078668. |
diabetic retinopathy (dr) is currently the leading cause of blindness in american adults, affecting over 7.7 million individuals and disproportionately affecting black americans. |
2022-01-26 |
2023-08-13 |
Not clear |
| Reanna Rodriguez, Kristine Lowe, Megan Keniry, Andrew Tsi. Involvement of TGFβ signaling pathway in oxidative stress and diabetic retinopathy. Archives of clinical and experimental ophthalmology. vol 3. issue 2. 2022-01-24. PMID:35072165. |
diabetic retinopathy (dr) is a leading cause of blindness in the u.s. |
2022-01-24 |
2023-08-13 |
Not clear |
| Muhammad Mateen, Tauqeer Safdar Malik, Shaukat Hayat, Musab Hameed, Song Sun, Junhao We. Deep Learning Approach for Automatic Microaneurysms Detection. Sensors (Basel, Switzerland). vol 22. issue 2. 2022-01-22. PMID:35062506. |
in this case, accurate early detection of microaneurysms is helpful to cure dr before non-reversible blindness. |
2022-01-22 |
2023-08-13 |
Not clear |
| Ana Boned-Murillo, Henar Albertos-Arranz, María Dolores Diaz-Barreda, Elvira Orduna-Hospital, Ana Sánchez-Cano, Antonio Ferreras, Nicolás Cuenca, Isabel Pinill. Optical Coherence Tomography Angiography in Diabetic Patients: A Systematic Review. Biomedicines. vol 10. issue 1. 2022-01-21. PMID:35052768. |
diabetic retinopathy (dr) is the leading cause of legal blindness in the working population in developed countries. |
2022-01-21 |
2023-08-13 |
Not clear |
| Yongyan Shan, Qian Wang, Yitong Zhang, Xuewei Tong, Shengdan Pu, Yuxin Xu, Xinyuan Ga. High remnant cholesterol level is relevant to diabetic retinopathy in type 2 diabetes mellitus. Lipids in health and disease. vol 21. issue 1. 2022-01-21. PMID:35057797. |
diabetic retinopathy (dr) is the primary oculopathy causing blindness in diabetic patients. |
2022-01-21 |
2023-08-13 |
Not clear |
| Nur Yasmin Diana Binti Lokman Hakim, Steven Noble, Natasya Valentina Thomas, Binushi Sandunika Geegana Gamage, Ganeson-Koo Maxwell, Vijayendran Govindasamy, Kong-Yong Then, Anjan Kumar Das, Soon-Keng Cheon. Genetic Modification as a New Approach to Ameliorate the Therapeutic Efficacy of Stem Cells in Diabetic Retinopathy. European journal of ophthalmology. 2022-01-17. PMID:35037488. |
the current treatment strategy needs to be addressed since the active progression of dr may lead to permanent blindness. |
2022-01-17 |
2023-08-13 |
Not clear |
| Jie Zhang, Linlin Li, Fangwei Xi. Sesamin inhibits cellular inflammation of microglial cells in the retina and alleviates diabetic retinopathy. Journal of neurophysiology. 2022-01-12. PMID:35020533. |
diabetic retinopathy (dr) is the most common micro-vascular complication of diabetes, and the leading cause of vision loss and blindness globally. |
2022-01-12 |
2023-08-13 |
mouse |